Case Study: Pre-Revenue Life Sciences Company Raises $60M via Reg A+

Posted by Life Science Intelligence on Aug 11, 2021 10:53:04 AM

Regulation A+ allows companies to raise up to $75M per year from both accredited and non-accredited investors. A common question founders have is whether it is really possible for a life sciences company to do raises of that size via Reg A+, especially if they’re pre-revenue, even pre-clinical. And the answer is yes.

Read More

Medtech Startups: Eyevensys, Respira Labs, SleepCogni, & more

Posted by Life Science Intelligence on Aug 10, 2021 12:07:23 PM

LSI's Medtech Startup Tracker is focused exclusively on covering the privately-held innovators changing the medical device landscape.

This week in medtech deals approximately $124.5M in funding was raised across 4 deals, in addition to other undisclosed deals that were announced. This represents a significant decrease in weekly medtech fundraising when compared to last week’s $446.1M. Here are some of the top deals tracked:

Read More

Topics: Insider, Startup, Strategics, Medtech, Medtech Innovation Weekly Update

Medtech Startups: Neuro42, OneraHealth, Sharper Sense & more

Posted by Life Science Intelligence on Aug 4, 2021 6:59:22 AM

LSI's Medtech Startup Tracker is focused exclusively on covering the privately-held innovators changing the medical device landscape.

This week in medtech deals approximately $446M in funding was raised across 12 deals, in addition to several other undisclosed deals that were announced. This is a sizable increase in funds raised when compared to last week’s $111M. Here are some of the top deals tracked:

Read More

Topics: Startup, Strategics, Medtech, Medtech Innovation Weekly Update

Why Now Is the Time to Raise Capital

Posted by Life Science Intelligence on Jul 28, 2021 7:06:08 AM

If you’ve been paying any attention to the news, you know that the pandemic has brought about a sea change in the role of retail investors. Last year saw Reddit users taking on institutional investors. This week, Robinhood is defying convention and reserving 35% of its IPO for retail investors through its app. Last week, retail dip buyers drove the rally against the Monday plunge in reaction to concerns about the corona delta variant.

But here’s the macro story underneath that’s not making the big headlines:  investors have cash and are eager to deploy it. According to Bloomberg, there’s $17 Trillion Burning a Hole in Pockets

Read More

Medtech Startups: HeartFlow, PathoGene, Farapulse, & more

Posted by Life Science Intelligence on Jul 28, 2021 6:00:00 AM

LSI's Medtech Startup Tracker is focused exclusively on covering the privately-held innovators changing the medical device landscape.

This week in medtech deals sees a significant dip following lasts weeks staggering ~$500M in funding. An estimated $111M in funding was raised across 3 deals in the past week, with the single biggest deal being attributed to NeuSpera Medical, which announced that it had raised $65M on July 20th.

Start a Free Trial to Medtech Startup Tracker Today

Read More

Topics: Insider, Startup, Strategics, Medtech, Medtech Innovation Weekly Update

EyeMarker Systems Engages Medical Funding Professionals to Implement Capital Planning Valuation Strategy™

Posted by Life Science Intelligence on Jul 22, 2021 11:07:58 AM

Life Science Intelligence (LSI) is pleased to announce that EyeMarker Systems has engaged our strategic partner Medical Funding Professionals (MFP) to implement their Capital Planning Valuation Strategy™ in furtherance of EyeMarker’s business plan.

EyeMarker Systems is the creator of BRAD-BIT, an innovative, portable, and accurate detection and tracking solution for traumatic brain injury. Traumatic Brain Injury (TBI) is a silent epidemic. 69 million people worldwide are estimated to sustain a TBI each year, from a range of causes including traffic accidents, athletic participation, falling injuries, violence, and combat. This epidemic is called “silent” because the injuries and symptoms often go unrecognized and untreated. The problems worsen with repeat injuries, especially if the brain is not given adequate recovery time after an incident. This makes early, accurate detection and ready availability of an individual’s previous results critical for both recovery and prevention of chronic symptoms.

Read More

Medtech Startups: Imperative Care, Swift Medical, IntuiTap, & more

Posted by Life Science Intelligence on Jul 21, 2021 6:00:00 AM

LSI's Medtech Startup Tracker is focused exclusively on covering the privately-held innovators changing the medical device landscape.

This week in medtech deals an over $492M in funding was raised across 12 deals, in addition to several other undisclosed deals that were announced. Here are some of the top deals tracked:

Start a Free Trial to Medtech Startup Tracker Today

Read More

Topics: Insider, Startup, Strategics, Medtech, Medtech Innovation Weekly Update

Digital Surgery 4.0 and The Power of Go, Go, Go

Posted by Life Science Intelligence on Jul 16, 2021 7:52:03 AM

Original publishing: July 12th, 2021 by Lisa Carmel, Vice President of Strategy at Ximedica.

Original publishing: https://www.ximedica.com/blog/digital-surgery-4-0-the-power-of-go-go-go/

 

Scott Huennekens is one of the inspirations for this Medtech Pioneers blog. When I heard he and Vince Burgess were planning an IPO of Acutus Medical in the midst of the pandemic, I knew I wanted to amplify leadership voices, like Scott’s, which have been driving disruptive progress despite huge hurdles. Scott has an amazing career which spans affiliations with over 20 medtech and biotech company boards, of which 6 have gone public (Digirad, Volcano, EndoChoice, Envista, Acutus and Hyperfine) and 10 have had significant exits over $300 million.

Read More

Topics: Medtech, Medtech Venture Capital

Kurve Therapeutics Engages Medical Funding Professionals to Implement Capital Planning Valuation Strategy™

Posted by Life Science Intelligence on Jul 15, 2021 9:18:49 AM

Life Science Intelligence (LSI) is pleased to announce that Kurve Therapeutics has engaged our strategic partner Medical Funding Professionals to implement their Capital Planning Valuation Strategy™ in furtherance of Kurve’s business plan.

Kurve Therapeutics is a specialty-drug company focused on next-generation treatments for neurodegenerative diseases. Current therapies for these disorders, especially complex molecules such as monoclonal antibodies, stem cells and larger peptides, have trouble crossing the blood brain barrier (BBB). Kurve’s patented Controlled Particle Dispersion® intranasal drug delivery technology creates a precisely-controlled turbulent flow that navigates the curved, complex geometry of the nasal cavity and accesses the olfactory region, bypassing the BBB, resulting in a delivery of up to 30 times more medicine to the brain than oral or intravenous delivery.

Read More

Medtech Startups: Osso VR, Sense Relief, Lumos Diagnostics, & more

Posted by Life Science Intelligence on Jul 14, 2021 8:58:20 AM

LSI's Medtech Startup Tracker is focused exclusively on covering the privately-held innovators changing the medical device landscape.

This week in medtech deals an over $119M in funding was raised across 7 deals, in addition to a number of other undisclosed deals that were announced. Here are some of the top deals tracked:

Start a Free Trial to Medtech Startup Tracker Today

Read More

Topics: Insider, Startup, Strategics, Medtech